Concepts (52)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psoriasis | 4 | 2024 | 45 | 2.240 |
Why?
|
| Population Health | 2 | 2023 | 35 | 1.690 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2024 | 131 | 0.910 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2024 | 147 | 0.830 |
Why?
|
| Crohn Disease | 1 | 2024 | 283 | 0.730 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2023 | 199 | 0.700 |
Why?
|
| Lung Neoplasms | 3 | 2025 | 1586 | 0.680 |
Why?
|
| Genome-Wide Association Study | 2 | 2024 | 1635 | 0.680 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 3084 | 0.440 |
Why?
|
| Case-Control Studies | 4 | 2024 | 3257 | 0.340 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 3342 | 0.280 |
Why?
|
| Polyadenylation | 1 | 2025 | 54 | 0.230 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2024 | 106 | 0.230 |
Why?
|
| United Kingdom | 1 | 2024 | 194 | 0.220 |
Why?
|
| Linkage Disequilibrium | 1 | 2024 | 306 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2024 | 187 | 0.210 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 137 | 0.210 |
Why?
|
| Patients | 1 | 2023 | 120 | 0.210 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2023 | 54 | 0.200 |
Why?
|
| Smoking | 2 | 2024 | 1029 | 0.200 |
Why?
|
| Colitis, Ulcerative | 1 | 2024 | 211 | 0.190 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 538 | 0.180 |
Why?
|
| Macrophages | 1 | 2024 | 613 | 0.180 |
Why?
|
| United States | 3 | 2024 | 10564 | 0.180 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2024 | 316 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2024 | 2584 | 0.150 |
Why?
|
| Comorbidity | 1 | 2023 | 1491 | 0.150 |
Why?
|
| Skin Neoplasms | 1 | 2024 | 805 | 0.140 |
Why?
|
| Phenotype | 2 | 2024 | 4222 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2025 | 1885 | 0.140 |
Why?
|
| Humans | 10 | 2025 | 122971 | 0.140 |
Why?
|
| Aged | 4 | 2024 | 18998 | 0.120 |
Why?
|
| Quality of Life | 1 | 2023 | 1921 | 0.110 |
Why?
|
| Middle Aged | 4 | 2024 | 25885 | 0.110 |
Why?
|
| Risk Factors | 2 | 2024 | 9950 | 0.100 |
Why?
|
| Adult | 4 | 2024 | 28944 | 0.100 |
Why?
|
| Male | 4 | 2024 | 59957 | 0.070 |
Why?
|
| Female | 4 | 2024 | 65361 | 0.070 |
Why?
|
| Cleavage Stimulation Factor | 1 | 2025 | 5 | 0.060 |
Why?
|
| Prognosis | 2 | 2024 | 4503 | 0.060 |
Why?
|
| Genes, myc | 1 | 2024 | 99 | 0.060 |
Why?
|
| Ultraviolet Rays | 1 | 2024 | 205 | 0.060 |
Why?
|
| Propensity Score | 1 | 2024 | 203 | 0.050 |
Why?
|
| Interferon Regulatory Factors | 1 | 2023 | 40 | 0.050 |
Why?
|
| Hepacivirus | 1 | 2024 | 242 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 267 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2024 | 520 | 0.050 |
Why?
|
| Hepatitis C | 1 | 2024 | 368 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2024 | 736 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2025 | 2833 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 1680 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2024 | 1431 | 0.030 |
Why?
|